Nascent Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 18, 2026	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Market Capitalization	0	31	7	6	6	12
Market Cap Growth	-99.78%	338.51%	13.54%	-0.40%	-47.12%	122.34%
Enterprise Value	-	31	7	6	6	12
Last Close Price	0.00	0.18	0.06	0.06	0.06	0.27
PS Ratio	-	-	-	6.31	8.45	-
PB Ratio	-0.10	-122.36	-5.53	-9.39	-13.40	-4.16
P/OCF Ratio	-	-	-	15.26	-	-
EV/Sales Ratio	-	-	-	6.47	8.52	-
Debt / Equity Ratio	-0.11	-0.48	-0.30	-	-0.34	-0.05
Net Debt / Equity Ratio	-0.02	0.97	-0.17	0.14	-0.34	-0.05
Asset Turnover	-	-	-	2.33	1.99	-
Quick Ratio	0.06	0.46	0.11	0.12	0.61	0.00
Current Ratio	0.31	0.68	0.16	0.14	0.61	0.00
Return on Assets (ROA)	-854.34%	-345.34%	-747.66%	-66.68%	-231.96%	-3199.30%
Return on Capital Employed (ROCE)	406.90%	868.80%	166.30%	68.10%	296.40%	119.90%
Earnings Yield	-3712.12%	-6.65%	-39.11%	-7.46%	-15.14%	-33.43%
Buyback Yield / Dilution	-30.53%	-31.35%	-10.05%	-48.93%	-110.34%	-14.30%

Updated Aug 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.